Genetic variants, circulating levels of monocyte chemoattractant protein-1 with risk of breast cancer: a case-control study and Mendelian randomization analysis / 中华预防医学杂志

Objective: To assess the association of genetic polymorphisms and circulating levels of chemokine monocyte chemoattractant protein-1 (MCP1) with risk of breast cancer. Methods: A total of 820 patients with pathologically confirmed breast cancer and 900 age-and area-of-residence-matched healthy controls who visited the hospital for routine health screening during the same period were included in this case-control study. Mendelian randomization analysis was performed using three widely followed functional single nucleotide polymorphisms (SNPs) of the MCP1 gene rs1024611, rs2857656 and rs4586 to construct instrumental variables . Results: MCP1 rs1024611 (OR=1.26, P=0.002), rs2857656 (OR=1.23, P=0.006) and rs4586 (OR=1.23, P=0.003) were significantly associated with increased risk of breast cancer. SNP rs1024611 (β=1.194, P<0.001), rs2857656 (β=1.221, P<0.001) and rs4586 (β=1.137, P<0.001) were positively correlated with higher circulating level of MCP1. The case-control study showed that an increase of 23.7 pg/ml of circulating levels of MCP1 was associated with a 0.25-fold increased risk of breast cancer. MR analysis confirmed that the genetic predicted circulating levels of MCP1 were associated with an increased risk of breast cancer, and the risk of breast cancer increased by 0.20 times with an increase of 23.7 pg/ml in MCP1. Conclusion: Genetic variants and circulating levels of MCP1 are significantly associated with the risk of breast cancer and can be used as a biomarker for early prediction of breast cancer.

The role of MTA1 protein in the invasion and metastasis of breast cancer / 肿瘤

Objective: To investigate the relationship between metastasis-associated gene 1 (MTA1) expression and the biological behaviors on human breast cancer. Methods: SP immunohistochemical technique was used to detect the expression of MTA1 protein among 116 human breast cancer samples and matched normal breast tissues. Results: (1) The expression of MTA1 was significantly higher in the breast cancer tissues than those of matched normal breast tissues (70.7% vs 10.3%, P < 0.05). (2) MTA1 protein had significantly higher expression in grade III-IV, low-differentiated, and axillary lymph node metastatic breast cancer tissues than those at grade I-II, high or middle differentiated, and without axillary lymph node metastasis (P < 0.05). Conclusion: There is a positive association between the expression of MTA1 and clinical stage, histological grade, and lymph node metastasis of breast cancer. MTA1 is a metastasis-facilitated protein and can be used as a prognostic marker for detection of recurrence and metastasis of breast cancer.

Expression of telomerase gene and apoptosis related protein in breast carcinoma / 肿瘤研究与临床

Objective To analyze the expression of telomerase and apoptosis related protein,and ex- plore the possible mechanism of breast cancer development.Methods Immunohistochemistry method(SP)was used to detect the expression of hTERT,p53 and bcl-2 in the tissues of 48 cases of human breast cancer and 42 cases of benign lesion in breast.Results The positive rates of expression of hTERT,p53 and bcl-2 in breast cancer were 87.50%,56.25%,54.17%,respectively;Compared with the groups of adjacent non- cancerous and benign lesions,there was a significant difference in three types of tissue(P